Board Change • May 20
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 9 highly experienced directors. No independent directors (5 non-independent directors). Independent Commissioner Marsillam Simandjuntak was the last independent director to join the board, commencing their role in 2010. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Apr 29
PT Medco Energi Internasional Tbk, Annual General Meeting, Jun 04, 2026 PT Medco Energi Internasional Tbk, Annual General Meeting, Jun 04, 2026. Announcement • Apr 23
PT Medco Energi Internasional Tbk, Annual General Meeting, Jun 03, 2025 PT Medco Energi Internasional Tbk, Annual General Meeting, Jun 03, 2025. Announcement • Mar 27
PT Medco Energi Internasional Tbk (IDX:MEDC) announces an Equity Buyback for IDR 820,000 million worth of its shares. PT Medco Energi Internasional Tbk (IDX:MEDC) announces a share repurchase program. Under the program, the company will repurchase up to IDR 820,000 million worth of its shares. Reported Earnings • Nov 01
Third quarter 2024 earnings released: EPS: US$0.003 (vs US$0.005 in 3Q 2023) Third quarter 2024 results: EPS: US$0.003 (down from US$0.005 in 3Q 2023). Revenue: US$642.0m (up 19% from 3Q 2023). Net income: US$75.4m (down 36% from 3Q 2023). Profit margin: 12% (down from 22% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to decline by 5.1% p.a. on average during the next 3 years, while revenues in the Oil and Gas industry in Europe are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 38% per year whereas the company’s share price has increased by 41% per year. Upcoming Dividend • Oct 07
Upcoming dividend of Rp15.75 per share Eligible shareholders must have bought the stock before 14 October 2024. Payment date: 01 November 2024. Payout ratio is a comfortable 10% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (2.5%). Reported Earnings • Aug 02
Second quarter 2024 earnings released: EPS: US$0.005 (vs US$0.001 in 2Q 2023) Second quarter 2024 results: EPS: US$0.005 (up from US$0.001 in 2Q 2023). Revenue: US$621.2m (up 14% from 2Q 2023). Net income: US$129.3m (up 292% from 2Q 2023). Profit margin: 21% (up from 6.0% in 2Q 2023). Revenue is expected to decline by 3.8% p.a. on average during the next 3 years, while revenues in the Oil and Gas industry in Germany are expected to grow by 37%. Over the last 3 years on average, earnings per share has increased by 53% per year and the company’s share price has also increased by 53% per year. Announcement • Apr 25
PT Medco Energi Internasional Tbk, Annual General Meeting, May 30, 2024 PT Medco Energi Internasional Tbk, Annual General Meeting, May 30, 2024. Reported Earnings • Apr 02
Full year 2023 earnings released: EPS: US$0.015 (vs US$0.021 in FY 2022) Full year 2023 results: EPS: US$0.015 (down from US$0.021 in FY 2022). Revenue: US$2.25b (flat on FY 2022). Net income: US$373.1m (down 28% from FY 2022). Profit margin: 17% (down from 23% in FY 2022). Revenue is expected to decline by 2.9% p.a. on average during the next 2 years, while revenues in the Oil and Gas industry in Germany are expected to grow by 1.2%. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth. Announcement • Nov 30
PT Medco Energi Internasional Tbk (IDX:MEDC) agreed to acquire 20% stake in Block 60 producing and Block 48 exploration licenses in Oman from Oq Exploration And Production. PT Medco Energi Internasional Tbk (IDX:MEDC) agreed to acquire 20% stake in Block 60 producing and Block 48 exploration licenses in Oman from Oq Exploration And Production on November 28, 2023. OQEP will remain the Operator of both Blocks. The transaction is now expected to complete in December 2023. Reported Earnings • Nov 05
Third quarter 2023 earnings released: EPS: US$0.005 (vs US$0.004 in 3Q 2022) Third quarter 2023 results: EPS: US$0.005 (up from US$0.004 in 3Q 2022). Revenue: US$541.9m (down 14% from 3Q 2022). Net income: US$118.4m (up 26% from 3Q 2022). Profit margin: 22% (up from 15% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is expected to decline by 2.3% p.a. on average during the next 3 years, while revenues in the Oil and Gas industry in Germany are expected to grow by 2.5%. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 73% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 05
Second quarter 2023 earnings released: EPS: US$0.001 (vs US$0.007 in 2Q 2022) Second quarter 2023 results: EPS: US$0.001 (down from US$0.007 in 2Q 2022). Revenue: US$568.7m (down 12% from 2Q 2022). Net income: US$33.0m (down 82% from 2Q 2022). Profit margin: 5.8% (down from 28% in 2Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is expected to decline by 3.4% p.a. on average during the next 3 years, while revenues in the Oil and Gas industry in Germany are expected to grow by 3.2%. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 99% per year, which means it is significantly lagging earnings growth. New Risk • Jul 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 22% per year for the foreseeable future. Minor Risks High level of debt (135% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change). Reported Earnings • May 24
First quarter 2023 earnings released: EPS: US$0.003 (vs US$0.004 in 1Q 2022) First quarter 2023 results: EPS: US$0.003 (down from US$0.004 in 1Q 2022). Revenue: US$558.1m (up 17% from 1Q 2022). Net income: US$79.9m (down 12% from 1Q 2022). Profit margin: 14% (down from 19% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 2.3% p.a. on average during the next 3 years, while revenues in the Oil and Gas industry in Germany are expected to grow by 2.8%. Over the last 3 years on average, earnings per share has increased by 120% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth. Reported Earnings • Dec 02
Third quarter 2022 earnings released: EPS: US$0.005 (vs US$0 in 3Q 2021) Third quarter 2022 results: EPS: US$0.005 (up from US$0 in 3Q 2021). Revenue: US$681.2m (up 120% from 3Q 2021). Net income: US$128.4m (up US$118.5m from 3Q 2021). Profit margin: 19% (up from 3.2% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is expected to decline by 1.9% p.a. on average during the next 3 years, while revenues in the Oil and Gas industry in Germany are expected to grow by 4.3%. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. No independent directors (5 non-independent directors). Independent Commissioner Bambang Subianto was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: US$0.007 (vs US$0.001 in 2Q 2021) Second quarter 2022 results: EPS: US$0.007 (up from US$0.001 in 2Q 2021). Revenue: US$668.6m (up 105% from 2Q 2021). Net income: US$179.5m (up 430% from 2Q 2021). Profit margin: 27% (up from 10% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 47%, compared to a 53% growth forecast for the Oil and Gas industry in Germany. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 14
Full year 2021 earnings released: EPS: US$0.002 (vs US$0.008 loss in FY 2020) Full year 2021 results: EPS: US$0.002 (up from US$0.008 loss in FY 2020). Revenue: US$1.32b (up 25% from FY 2020). Net income: US$38.2m (up US$220.5m from FY 2020). Profit margin: 2.9% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the next year, revenue is forecast to grow 60%, compared to a 61% growth forecast for the oil industry in Germany. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. No independent directors (5 non-independent directors). Independent Commissioner Bambang Subianto was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Dec 23
Third quarter 2021 earnings: Revenues miss analyst expectations Third quarter 2021 results: Revenue: US$338.5m (up 40% from 3Q 2020). Net income: US$9.97m (up US$83.1m from 3Q 2020). Profit margin: 2.9% (up from net loss in 3Q 2020). Revenue missed analyst estimates by 5.0%. Over the next year, revenue is forecast to grow 18%, compared to a 54% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Reported Earnings • Oct 29
Second quarter 2021 earnings released: EPS US$0.001 (vs US$0.002 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$345.5m (up 32% from 2Q 2020). Net income: US$33.9m (up US$71.0m from 2Q 2020). Profit margin: 9.8% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Breakeven Date Change • Sep 23
Forecast to breakeven in 2021 The 4 analysts covering Medco Energi Internasional expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$109.8m in 2021. Earnings growth of 46% is required to achieve expected profit on schedule. Announcement • Jun 05
PT Medco Energi Internasional Tbk (IDX:MEDC) acquired additional 2% stake in PT Amman Mineral Internasiona for IDR 730 billion. PT Medco Energi Internasional Tbk (IDX:MEDC) signed an agreement to acquire additional 2% stake in PT Amman Mineral Internasiona for IDR 730 billion on May 1, 2021.
PT Medco Energi Internasional Tbk (IDX:MEDC) completed the acquisition of additional 2% stake in PT Amman Mineral Internasiona on June 4, 2021. Reported Earnings • Dec 02
Third quarter 2020 earnings released: US$0.004 loss per share The company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: US$241.1m (down 38% from 3Q 2019). Net loss: US$73.1m (loss widened 386% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 139% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings. Announcement • Oct 29
Eni Reportedly Expects Binding Bids for Australian Gas Assets by End November Eni S.p.A. (BIT:ENI) and its adviser Citi expect binding bids for the Italian energy group's gas assets in Australia by the end of November (2020) in a deal that could raise around $1 Billion, two sources said. Indonesia's PT Medco Energi Internasional Tbk (IDX:MEDC) and a consortium comprising Australian fund Macquarie Group Limited (ASX:MQG) and Neptune Energy Australia Pty Limited are working on bids, the sources said. Morgan Stanley Infrastructure Inc. has also expressed an interest, one person said. “The sale has generated limited interest,” one of the sources said. The Australia sale is part of Eni’s plans to sell non-core assets to raise cash after the global downturn triggered by the coronavirus pandemic, and its drive to focus on cleaner fuels. “The sale will not include the solar assets the group has there,” one source said. The oil and gas major is also looking to sell assets in Pakistan and the Congo, one of the sources said, without giving further details. Eni, Neptune and Macquarie declined to comment. Medco and Morgan Stanley were not immediately available for comment. Reported Earnings • Oct 08
First half earnings released Over the last 12 months the company has reported total losses of US$114.8m, with losses widening by 234% from the prior year. Total revenue was US$1.39b over the last 12 months, up 12% from the prior year. 
